PHK
RPRX icon

Point72 Hong Kong’s Royalty Pharma RPRX Stock Holding History

Point72 Hong Kong’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,789
Closed -$814K – 689
2024
Q1 		$814K Sell
26,789
-87,836
-77% -$2.59M 0.04% 294
2023
Q4 		$3.22M Buy
+114,625
New +$3.15M 0.2% 144
2022
Q1 		– Sell
-6,480
Closed -$258K – 2298
2021
Q4 		$258K Buy
+6,480
New +$252K 0.02% 946
2021
Q3 		– Sell
-5,377
Closed -$220K – 2392
2021
Q2 		$220K Buy
+5,377
New +$229K 0.02% 1134
2020
Q3 		– Sell
-37,659
Closed -$1.83M – 1487
2020
Q2 		$1.83M Buy
+37,659
New +$1.86M 0.21% 127

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return